Keyphrases
Early Breast Cancer
50%
Meta-analysis
34%
Breast Cancer
30%
Sarcopenia
30%
Chemotherapy
29%
Systematic Meta-analysis
22%
Body Composition
21%
Confidence Interval
17%
Endocrine Treatment
16%
Adult Cancer
16%
Treatment Toxicity
15%
Weight Gain
15%
Body Mass Index
14%
Overall Survival
14%
Geriatric Assessment
14%
Breast Cancer Patients
13%
Comorbidity
12%
Older Women
12%
Hormone Receptor-positive
12%
Older Patients
12%
In Cancer
12%
Relative Risk
11%
Hazard Ratio
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Adverse Events
11%
Hormone Receptor
10%
Skeletal muscle Density
9%
Skeletal muscle Index
9%
Older Adults
9%
Breast Cancer Recurrence
9%
Black Women
9%
Metastatic Breast Cancer
9%
Very Severe
8%
Breast Cancer during Pregnancy
8%
Prognostic Value
8%
White Women
8%
Solid Tumors
8%
Clinician Rating
8%
Alpelisib
8%
Aging Biomarkers
8%
Multidisciplinary Management
8%
Myosteatosis
8%
Adjuvant Endocrine Therapy
8%
Quality of Life
8%
Adjuvant Chemotherapy
7%
Young Patients
7%
Anthracyclines
7%
Breast Cancer Diagnosis
7%
Frailty
7%
Patient Characteristics
7%
Medicine and Dentistry
Breast Cancer
100%
Systematic Review
34%
Skeletal Muscle
34%
Sarcopenia
33%
Malignant Neoplasm
31%
Meta-Analysis
29%
Hormone Receptor
21%
Metastatic Breast Cancer
20%
Hormone Therapy
19%
Overall Survival
17%
Adverse Event
13%
Neoplasm
12%
Metastatic Carcinoma
12%
Frailty
11%
Quality of Life
11%
Oncology
11%
Cancer Diagnosis
11%
Hazard Ratio
10%
Comorbidity
10%
Geriatric Assessment
9%
Solid Malignant Neoplasm
9%
Body Mass Index
9%
Adipose Tissue
9%
Recurrent Disease
8%
Alpelisib
8%
Computer Assisted Tomography
7%
Gamma Urogastrone
6%
Patient Characteristics
6%
Epidermal Growth Factor Receptor 2
6%
Anthracycline
6%
Adjuvant Chemotherapy
6%
Breast Carcinoma
5%
Clinical Trial
5%
Tumor Progression
5%
Intraductal Carcinoma
5%
Randomized Controlled Trial
5%
Clinician
5%
Prospective Study
5%
Adjuvant Therapy
5%